tiprankstipranks
Trending News
More News >
Medical Facilities Corporation (MFCSF)
OTHER OTC:MFCSF
US Market
Advertisement

Medical Facilities (MFCSF) Ratios

Compare
40 Followers

Medical Facilities Ratios

MFCSF's free cash flow for Q2 2025 was $0.66. For the 2025 fiscal year, MFCSF's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.58 1.24 1.37 1.83 1.44
Quick Ratio
1.48 1.13 1.27 1.70 1.35
Cash Ratio
0.78 0.29 0.40 0.75 0.65
Solvency Ratio
0.57 0.17 0.13 0.27 0.23
Operating Cash Flow Ratio
0.98 0.88 0.66 0.93 0.86
Short-Term Operating Cash Flow Coverage
12.74 5.07 5.86 14.29 4.59
Net Current Asset Value
$ -74.40M$ -133.82M$ -143.77M$ -118.39M$ -135.23M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.33 0.38 0.32 0.35
Debt-to-Equity Ratio
0.89 1.36 1.81 1.05 1.27
Debt-to-Capital Ratio
0.47 0.58 0.64 0.51 0.56
Long-Term Debt-to-Capital Ratio
0.27 0.39 0.49 0.36 0.38
Financial Leverage Ratio
3.60 4.13 4.77 3.33 3.58
Debt Service Coverage Ratio
20.75 2.08 2.76 3.19 2.75
Interest Coverage Ratio
-47.14 4.07 3.64 3.01 4.72
Debt to Market Cap
0.17 0.40 0.49 0.35 0.57
Interest Debt Per Share
3.22 5.26 5.31 5.36 5.67
Net Debt to EBITDA
0.25 1.28 1.60 0.77 1.00
Profitability Margins
Gross Profit Margin
65.05%66.58%66.10%67.38%66.77%
EBIT Margin
19.81%11.42%7.16%19.22%18.73%
EBITDA Margin
26.24%16.26%15.95%25.94%26.40%
Operating Profit Margin
18.41%15.06%11.06%19.41%18.63%
Pretax Profit Margin
20.22%11.74%4.12%12.77%11.48%
Net Profit Margin
28.90%4.15%2.90%11.66%10.28%
Continuous Operations Profit Margin
21.66%9.87%2.90%11.66%10.28%
Net Income Per EBT
142.94%35.36%70.25%91.36%89.57%
EBT Per EBIT
109.84%77.97%37.29%65.78%61.63%
Return on Assets (ROA)
29.34%5.21%3.25%10.40%8.19%
Return on Equity (ROE)
90.38%21.52%15.54%34.67%29.34%
Return on Capital Employed (ROCE)
24.21%24.68%16.13%21.16%19.08%
Return on Invested Capital (ROIC)
24.45%19.10%10.61%18.58%15.84%
Return on Tangible Assets
45.53%8.30%5.04%15.68%12.50%
Earnings Yield
37.45%10.78%7.06%20.23%21.77%
Efficiency Ratios
Receivables Turnover
6.38 7.21 6.63 5.91 5.66
Payables Turnover
7.05 6.43 5.45 5.43 4.94
Inventory Turnover
15.01 16.53 15.60 12.21 12.96
Fixed Asset Turnover
3.59 3.71 3.40 3.00 2.64
Asset Turnover
1.02 1.26 1.12 0.89 0.80
Working Capital Turnover Ratio
7.68 17.04 8.50 7.09 6.24
Cash Conversion Cycle
29.78 15.92 11.50 24.45 18.75
Days of Sales Outstanding
57.22 50.60 55.06 61.76 64.44
Days of Inventory Outstanding
24.31 22.08 23.40 29.89 28.16
Days of Payables Outstanding
51.75 56.75 66.96 67.20 73.85
Operating Cycle
81.53 72.68 78.46 91.65 92.60
Cash Flow Ratios
Operating Cash Flow Per Share
2.96 2.87 1.94 2.43 2.80
Free Cash Flow Per Share
2.79 2.24 1.71 2.16 2.56
CapEx Per Share
0.17 0.63 0.23 0.27 0.24
Free Cash Flow to Operating Cash Flow
0.94 0.78 0.88 0.89 0.91
Dividend Paid and CapEx Coverage Ratio
6.51 3.29 4.01 4.93 6.49
Capital Expenditure Coverage Ratio
17.05 4.53 8.49 8.98 11.58
Operating Cash Flow Coverage Ratio
0.90 0.62 0.40 0.54 0.54
Operating Cash Flow to Sales Ratio
0.22 0.16 0.13 0.19 0.24
Free Cash Flow Yield
29.35%33.02%28.88%29.25%46.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
2.67 9.27 14.17 4.94 4.59
Price-to-Sales (P/S) Ratio
0.71 0.39 0.41 0.58 0.47
Price-to-Book (P/B) Ratio
2.82 2.00 2.20 1.71 1.35
Price-to-Free Cash Flow (P/FCF) Ratio
3.41 3.03 3.46 3.42 2.16
Price-to-Operating Cash Flow Ratio
3.51 2.36 3.06 3.04 1.97
Price-to-Earnings Growth (PEG) Ratio
0.42 0.13 -0.20 0.20 -0.12
Price-to-Fair Value
2.82 2.00 2.20 1.71 1.35
Enterprise Value Multiple
2.94 3.65 4.17 3.00 2.79
Enterprise Value
214.84M 264.30M 282.21M 309.70M 267.63M
EV to EBITDA
2.94 3.65 4.17 3.00 2.79
EV to Sales
0.77 0.59 0.66 0.78 0.74
EV to Free Cash Flow
3.73 4.66 5.61 4.61 3.36
EV to Operating Cash Flow
3.51 3.63 4.95 4.09 3.07
Tangible Book Value Per Share
0.15 -0.54 -0.65 0.94 0.56
Shareholders’ Equity Per Share
3.69 3.39 2.69 4.31 4.10
Tax and Other Ratios
Effective Tax Rate
-0.07 0.16 0.30 0.09 0.10
Revenue Per Share
13.48 17.58 14.46 12.82 11.70
Net Income Per Share
3.90 0.73 0.42 1.50 1.20
Tax Burden
1.43 0.35 0.70 0.91 0.90
Interest Burden
1.02 1.03 0.58 0.66 0.61
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.45 0.34 0.47 0.45 0.48
Stock-Based Compensation to Revenue
>-0.01 >-0.01 >-0.01 <0.01 <0.01
Income Quality
0.56 1.65 4.64 1.63 2.44
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis